- Home
- PHAR vs DEC Comparison
PHAR vs DEC Comparison
Compare PHAR & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- DEC
- Stock Information
- Founded
- PHAR 1988
- DEC 2001
- Country
- PHAR Netherlands
- DEC United States
- Employees
- PHAR N/A
- DEC N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- DEC
- Sector
- PHAR Health Care
- DEC
- Exchange
- PHAR Nasdaq
- DEC Nasdaq
- Market Cap
- PHAR 951.7M
- DEC 1.0B
- IPO Year
- PHAR N/A
- DEC N/A
- Fundamental
- Price
- PHAR $13.18
- DEC $13.71
- Analyst Decision
- PHAR Strong Buy
- DEC Strong Buy
- Analyst Count
- PHAR 3
- DEC 4
- Target Price
- PHAR $30.00
- DEC $21.50
- AVG Volume (30 Days)
- PHAR 9.7K
- DEC 403.3K
- Earning Date
- PHAR 11-06-2025
- DEC 01-01-0001
- Dividend Yield
- PHAR N/A
- DEC 8.46%
- EPS Growth
- PHAR N/A
- DEC N/A
- EPS
- PHAR N/A
- DEC N/A
- Revenue
- PHAR $339,836,000.00
- DEC $1,148,432,000.00
- Revenue This Year
- PHAR $17.70
- DEC $128.26
- Revenue Next Year
- PHAR $12.25
- DEC N/A
- P/E Ratio
- PHAR N/A
- DEC N/A
- Revenue Growth
- PHAR 22.44
- DEC 64.19
- 52 Week Low
- PHAR $7.31
- DEC $10.08
- 52 Week High
- PHAR $17.08
- DEC $17.70
- Technical
- Relative Strength Index (RSI)
- PHAR 43.85
- DEC 57.21
- Support Level
- PHAR $13.03
- DEC $12.44
- Resistance Level
- PHAR $13.43
- DEC $12.73
- Average True Range (ATR)
- PHAR 0.49
- DEC 0.33
- MACD
- PHAR -0.10
- DEC 0.16
- Stochastic Oscillator
- PHAR 23.47
- DEC 89.60
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.